ÇETİN, M. Et Al. 2020. Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.42, no.3 , 271-274.

ÇETİN, M., ERDOGAN, T., KIRIS, T., OEZER, S., CINIER, G., EMLEK, N., ... DURAK, H.(2020). Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.42, no.3, 271-274.

ÇETİN, MUSTAFA Et Al. "Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.42, no.3, 271-274, 2020

ÇETİN, MUSTAFA Et Al. "Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.42, no.3, pp.271-274, 2020

ÇETİN, M. Et Al. (2020) . "Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.42, no.3, pp.271-274.

@article{article, author={MUSTAFA ÇETİN Et Al. }, title={Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients}, journal={CLINICAL AND EXPERIMENTAL HYPERTENSION}, year=2020, pages={271-274} }